-
公开(公告)号:US07517998B2
公开(公告)日:2009-04-14
申请号:US11137831
申请日:2005-05-24
申请人: Patrick Deroy , Anne-Marie Faucher , Alexandre Gagnon , Serge Landry , Sebastien Morin , Jeffrey O'Meara , Bruno Simoneau , Bounkham Thavonekham , Christiane Yoakim
发明人: Patrick Deroy , Anne-Marie Faucher , Alexandre Gagnon , Serge Landry , Sebastien Morin , Jeffrey O'Meara , Bruno Simoneau , Bounkham Thavonekham , Christiane Yoakim
IPC分类号: A61K31/41 , C07D257/04
CPC分类号: C07D257/04 , A61K31/41 , A61K31/4439 , A61K31/454 , A61K31/4709 , A61K31/495 , A61K31/5377 , A61K31/541 , C07D231/18 , C07D233/84 , C07D249/08 , C07D249/12 , C07D277/36 , C07D285/06 , C07D285/125 , C07D401/12 , C07D403/12 , C07D405/12 , C07D409/12 , C07D413/12
摘要: Compounds of formula (I): wherein Ar, X, R1, R2, R3 and R4 are as defined herein. The compounds are useful as reverse transcriptase inhibitors against wild type and single or double mutant strains of HIV.
摘要翻译: 式(I)化合物:其中Ar,X,R 1,R 2,R 3和R 4如本文所定义。 该化合物可用作针对野生型和单突变或双突变株的逆转录酶抑制剂。
-
公开(公告)号:US20050282907A1
公开(公告)日:2005-12-22
申请号:US11137831
申请日:2005-05-24
申请人: Patrick Deroy , Anne-Marie Faucher , Alexandre Gagnon , Serge Landry , Sebastien Morin , Jeffrey O'Meara , Bruno Simoneau , Bounkham Thavonekham , Christiane Yoakim
发明人: Patrick Deroy , Anne-Marie Faucher , Alexandre Gagnon , Serge Landry , Sebastien Morin , Jeffrey O'Meara , Bruno Simoneau , Bounkham Thavonekham , Christiane Yoakim
IPC分类号: A61K31/165 , A61K31/41 , A61K31/4439 , A61K31/454 , A61K31/4709 , A61K31/495 , A61K31/5377 , A61K31/541 , A61P31/18 , C07D231/18 , C07D233/84 , C07D249/04 , C07D249/08 , C07D249/10 , C07D249/12 , C07D257/04 , C07D277/36 , C07D285/06 , C07D285/12 , C07D285/125 , C07D401/12 , C07D403/12 , C07D405/12 , C07D409/12 , C07D413/12
CPC分类号: C07D257/04 , A61K31/41 , A61K31/4439 , A61K31/454 , A61K31/4709 , A61K31/495 , A61K31/5377 , A61K31/541 , C07D231/18 , C07D233/84 , C07D249/08 , C07D249/12 , C07D277/36 , C07D285/06 , C07D285/125 , C07D401/12 , C07D403/12 , C07D405/12 , C07D409/12 , C07D413/12
摘要: Compounds of formula (I): wherein Ar, X, R1, R2, R3 and R4 are as defined herein. The compounds are useful as reverse transcriptase inhibitors against wild type and single or double mutant strains of HIV.
摘要翻译: 式(I)化合物:其中Ar,X,R 1,R 2,R 3和R 4, >如本文所定义。 该化合物可用作针对野生型和单突变或双突变株的逆转录酶抑制剂。
-
公开(公告)号:US08198458B2
公开(公告)日:2012-06-12
申请号:US12364551
申请日:2009-02-03
申请人: Patrick DeRoy , Anne-Marie Faucher , Alexandre Gagnon , Serge R. Landry , Sebastien Morin , Jeffrey O'Meara , Bruno Simoneau , Bounkham Thavonekham , Christiane Yoakim
发明人: Patrick DeRoy , Anne-Marie Faucher , Alexandre Gagnon , Serge R. Landry , Sebastien Morin , Jeffrey O'Meara , Bruno Simoneau , Bounkham Thavonekham , Christiane Yoakim
IPC分类号: A61K31/41 , C07D257/04
CPC分类号: C07D257/04 , A61K31/41 , A61K31/4439 , A61K31/454 , A61K31/4709 , A61K31/495 , A61K31/5377 , A61K31/541 , C07D231/18 , C07D233/84 , C07D249/08 , C07D249/12 , C07D277/36 , C07D285/06 , C07D285/125 , C07D401/12 , C07D403/12 , C07D405/12 , C07D409/12 , C07D413/12
摘要: Compounds of formula (I): wherein Ar, X, R1, R2, R3 and R4 are as defined herein. The compounds are useful as reverse transcriptase inhibitors against wild type and single or double mutant strains of HIV.
摘要翻译: 式(I)化合物:其中Ar,X,R 1,R 2,R 3和R 4如本文所定义。 该化合物可用作针对野生型和单突变或双突变株的逆转录酶抑制剂。
-
公开(公告)号:US08349839B2
公开(公告)日:2013-01-08
申请号:US12756276
申请日:2010-04-08
申请人: Claudio Sturino , Patrick Deroy , Martin Duplessis , Paul J. Edwards , Anne-Marie Faucher , Teddy Halmos , Clint James , Jean-Eric Lacoste , Eric Malenfant , Joannie Minville , Louis Morency , Sebastien Morin , Martin Tremblay , Christiane Yoakim
发明人: Claudio Sturino , Patrick Deroy , Martin Duplessis , Paul J. Edwards , Anne-Marie Faucher , Teddy Halmos , Clint James , Jean-Eric Lacoste , Eric Malenfant , Joannie Minville , Louis Morency , Sebastien Morin , Martin Tremblay , Christiane Yoakim
IPC分类号: A61K31/501 , A61K31/34 , C07D237/36 , C07D307/92
CPC分类号: C07D491/048 , C07D487/04 , C07D491/147 , C07D513/04 , C07D519/00
摘要: Compounds of formula (I): wherein R1, R2, A1, A2, A3, A4, X and Y are as defined herein, are useful as inhibitors of HIV replication.
摘要翻译: 式(I)化合物:其中R1,R2,A1,A2,A3,A4,X和Y如本文所定义,可用作HIV复制的抑制剂。
-
公开(公告)号:US08338441B2
公开(公告)日:2012-12-25
申请号:US12777406
申请日:2010-05-11
申请人: Christiane Yoakim , Murray Bailey , Francois Bilodeau , Rebekah Carson , Lee Fader , Stephen Kawai , Sebastien Morin , Carl Thibeault , Bruno Simoneau , Simon Surprenant , Youla Tsantrizos , Steven Laplante
发明人: Christiane Yoakim , Murray Bailey , Francois Bilodeau , Rebekah Carson , Lee Fader , Stephen Kawai , Sebastien Morin , Carl Thibeault , Bruno Simoneau , Simon Surprenant , Youla Tsantrizos , Steven Laplante
IPC分类号: A01N43/40 , A61K31/435
CPC分类号: C07D213/81 , A61K31/4375 , A61K31/44 , A61K31/4433 , A61K31/4436 , A61K31/4439 , A61K31/444 , A61K31/4709 , A61K31/4741 , A61K31/501 , A61K31/506 , A61K31/538 , A61K31/5383 , A61K45/06 , C07D213/55 , C07D401/12 , C07D405/10 , C07D405/14 , C07D411/10 , C07D413/10 , C07D413/14 , C07D417/10 , C07D471/04 , C07D491/06 , C07D498/06
摘要: Compounds of formula I: wherein a, R1, R2, R3, R4, R5 and R6 are defined herein, are useful as inhibitors of HIV replication.
摘要翻译: 式I化合物:其中a,R 1,R 2,R 3,R 4,R 5和R 6在本文中定义,可用作HIV复制的抑制剂。
-
公开(公告)号:US08354429B2
公开(公告)日:2013-01-15
申请号:US12742997
申请日:2008-09-11
申请人: Youla S. Tsantrizos , Murray D. Bailey , Francois Bilodeau , Rebekah J. Carson , Rene Coulombe , Lee Fader , Teddy Halmos , Stephen Kawai , Serge Landry , Steven LaPlante , Sebastien Morin , Mathieu Parisien , Marc-Andre Poupart , Bruno Simoneau
发明人: Youla S. Tsantrizos , Murray D. Bailey , Francois Bilodeau , Rebekah J. Carson , Rene Coulombe , Lee Fader , Teddy Halmos , Stephen Kawai , Serge Landry , Steven LaPlante , Sebastien Morin , Mathieu Parisien , Marc-Andre Poupart , Bruno Simoneau
IPC分类号: C07D215/14 , C07D401/04 , A61K31/47 , A61K31/4709
CPC分类号: C07D215/14 , A61K31/47 , A61K31/4709 , A61K31/473 , A61K31/4741 , A61K31/538 , A61K31/5383 , C07D215/18 , C07D221/16 , C07D401/04 , C07D405/04 , C07D409/04 , C07D413/04 , C07D417/04 , C07D491/06 , C07D498/06
摘要: Compounds of formula I: wherein R4, R6 and R7 are defined herein, are useful as inhibitors of HIV replication.
摘要翻译: 式I化合物(其中R 4,R 6和R 7在本文中定义)可用作HIV复制的抑制剂。
-
公开(公告)号:US07956068B2
公开(公告)日:2011-06-07
申请号:US12743143
申请日:2008-11-03
申请人: Rebekah J. Carson , Lee Fader , Stephen Kawai , Serge R. Landry , Youla S. Tsantrizos , Christian Brochu , Sebastien Morin , Mathieu Parisien , Bruno Simoneau
发明人: Rebekah J. Carson , Lee Fader , Stephen Kawai , Serge R. Landry , Youla S. Tsantrizos , Christian Brochu , Sebastien Morin , Mathieu Parisien , Bruno Simoneau
IPC分类号: C07D495/04 , A61K31/4365
CPC分类号: C07D495/04 , C07D519/00
摘要: The present invention relates to compounds of formula (I) wherein c, X, Y, R2, R3, R4 and R6 are as defined herein, compositions and uses thereof for treating human immunodeficiency virus (HIV) infection. In particular, the present invention provides novel inhibitors of HIV integrase, pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HIV infection.
摘要翻译: 本发明涉及其中c,X,Y,R 2,R 3,R 4和R 6如本文所定义的式(I)化合物,其用于治疗人类免疫缺陷病毒(HIV)感染的组合物和用途。 特别地,本发明提供HIV整合酶的新型抑制剂,含有这些化合物的药物组合物和使用这些化合物治疗HIV感染的方法。
-
公开(公告)号:US20100305115A1
公开(公告)日:2010-12-02
申请号:US12743143
申请日:2008-11-03
申请人: Rebekah J. Carson , Lee Fader , Stephen Kawai , Serge R. Landry , Youla S. Tsantrizos , Christian Brochu , Sebastien Morin , Mathieu Parisien , Bruno Simoneau
发明人: Rebekah J. Carson , Lee Fader , Stephen Kawai , Serge R. Landry , Youla S. Tsantrizos , Christian Brochu , Sebastien Morin , Mathieu Parisien , Bruno Simoneau
IPC分类号: A61K31/538 , C07D495/04 , A61K31/4365 , C07D491/06 , A61K31/436 , A61P31/18
CPC分类号: C07D495/04 , C07D519/00
摘要: The present invention relates to compounds of formula (I) wherein c, X, Y, R2, R3, R4 and R6 are as defined herein, compositions and uses thereof for treating human immunodeficiency virus (HIV) infection. In particular, the present invention provides novel inhibitors of HIV integrase, pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HIV infection
摘要翻译: 本发明涉及其中c,X,Y,R 2,R 3,R 4和R 6如本文所定义的式(I)化合物,其用于治疗人类免疫缺陷病毒(HIV)感染的组合物和用途。 特别地,本发明提供HIV整合酶的新型抑制剂,含有这些化合物的药物组合物和使用这些化合物治疗HIV感染的方法
-
公开(公告)号:US20100311735A1
公开(公告)日:2010-12-09
申请号:US12742997
申请日:2008-09-11
申请人: Youla S. Tsantrizos , Murray D. Bailey , Francois Bilodeau , Rene Coulombe , Teddy Halmos , Stephen Kawai , Serge R. Landry , Steven LaPlante , Sebastien Morin , Marc-Andre Poupart , Bruno Simoneau , Lee Fader , Rebekah J. Carson , Mathieu Parisien
发明人: Youla S. Tsantrizos , Murray D. Bailey , Francois Bilodeau , Rene Coulombe , Teddy Halmos , Stephen Kawai , Serge R. Landry , Steven LaPlante , Sebastien Morin , Marc-Andre Poupart , Bruno Simoneau , Lee Fader , Rebekah J. Carson , Mathieu Parisien
IPC分类号: A61K31/5383 , C07D215/14 , A61K31/47 , C07D405/10 , A61K31/4709 , C07D401/10 , C07D491/16 , A61K31/4741 , C07D413/10 , A61K31/538 , C07D498/06 , A61P31/18
CPC分类号: C07D215/14 , A61K31/47 , A61K31/4709 , A61K31/473 , A61K31/4741 , A61K31/538 , A61K31/5383 , C07D215/18 , C07D221/16 , C07D401/04 , C07D405/04 , C07D409/04 , C07D413/04 , C07D417/04 , C07D491/06 , C07D498/06
摘要: Compounds of formula I: wherein R4, R6 and R7 are defined herein, are useful as inhibitors of HIV replication.
摘要翻译: 式I化合物(其中R 4,R 6和R 7在本文中定义)可用作HIV复制的抑制剂。
-
公开(公告)号:US20090202114A1
公开(公告)日:2009-08-13
申请号:US12370200
申请日:2009-02-12
申请人: Sebastien Morin , Philippe Vimont
发明人: Sebastien Morin , Philippe Vimont
IPC分类号: G06K9/00
CPC分类号: A63F13/655 , A63F13/12 , A63F13/213 , A63F13/525 , A63F2300/5553 , A63F2300/6692 , A63F2300/69 , G06K9/00248 , G06T7/246 , G06T2207/10016 , G06T2207/30201
摘要: A computer-implemented video capture process includes identifying and tracking a face in a plurality of real-time video frames on a first computing device, generating first face data representative of the identified and tracked face, and transmitting the first face data to a second computing device over a network for display of the face on an avatar body by the second computing device.
摘要翻译: 计算机实现的视频捕获过程包括识别和跟踪第一计算设备上的多个实时视频帧中的面部,产生表示所识别和跟踪的面部的第一面部数据,以及将第一面部数据发送到第二计算 设备通过网络显示第二计算设备在化身主体上的脸部。
-
-
-
-
-
-
-
-
-